NCT01504074View on ClinicalTrials.gov

Morphological and Functional Evaluation of Irvine-Gass Syndrome

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2014

Conditions
Irvine Gass Syndrome
Interventions
BEHAVIORAL

if needed (decided individually) either Acular eye drops, Ultracortenol eye drop or intravitreal triamcinolone injection

if prescribed: Ultracortenol/ Acular eye drops 3-4 times a day, if prescribed: singular intravitreal triamcinolone injection

Trial Locations (1)

1190

Department of Ophthalmology Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01504074 - Morphological and Functional Evaluation of Irvine-Gass Syndrome | Biotech Hunter | Biotech Hunter